SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Zofia Piotrowska

Zofia Piotrowska

Massachusetts General Hospital, Boston

Dr. Zofia Piotrowska is a thoracic medical oncologist at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School in Boston, USA. Her research focuses on understanding and overcoming resistance to targeted therapies in lung cancer, particularly EGFR-mutant non-small cell lung cancer, and on integrating circulating tumor DNA (ctDNA) diagnostics into clinical care. She co-directs the Mass General Brigham Thoracic Medical Oncology Program, leads multiple early-phase EGFR-targeted clinical trials, and chairs the EGFR Resisters Research Summit. She is a frequent speaker at major international thoracic oncology congresses.

Connect

Zofia Piotrowska

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates